Tumbleweed

📂 Hardware & Deep Tech📍 Vienna🗓️ Founded: 2024

Tumbleweed combines Pod containers and Oasis orbital platforms to fly microgravity experiments without requiring customers to build satellite expertise.

Europe's most interesting startup stories. Every week.

No spam. Unsubscribe anytime.

Podcast Episode

🎙️ Deep Dive

Quint Computing, Enginsight, Tumbleweed — €9.1M for quantum, cyber growth and €6.9M for microgravity — Daily News November 3, 2026

Listen to the episode

About Tumbleweed

Tumbleweed grew out of Team Tumbleweed, which had worked on Mars rovers since 2016, and became an independent company in Vienna in November 2024, founded by Julian Rothenbuchner (CEO), Leonhard Goliasch (COO) and Guillaume Brault (CTO); a second office in Delft, the Netherlands, focuses on technology development. It offers Pods, modular containers in which labs and companies integrate experiments without aerospace expertise, and Oasis, an orbital platform that hosts them in flight. Oasis Alpha launched on July 7, 2026 on SpaceX Transporter-17 with four customers, including TU Delft, ESRIC and MassBalance. Missions start at €15,000. On November 3, 2026 it announced a €6.9 million seed round led by PactVC, with Vanagon Ventures, Prototype Capital and EWOR, Austria’s largest spacetech seed round: it will fund three missions in 2027 for more than ten customers and develop Oasis Beta, which will return samples to Earth from 2028.

The Story

Grew out of Team Tumbleweed, which had worked on Mars rovers since 2016; independent company since November 2024.

How Tumbleweed works

Business Model

B2B payload and mission service combining modular hardware with end-to-end orbital access.

Revenue Model

Per-payload and per-mission pricing, starting at €15,000.

Products & Services

Key Products

  • Pod
  • Oasis Alpha
  • Oasis Beta

Core Use Cases

  • Microgravity experiments
  • In-orbit technology validation
  • Biotech and pharma research
  • Materials research
  • Sample return (from 2028)

Market & Clients

Key Customers

Laboratories, universities, manufacturers and R&D teams in pharma, biotech, photonics, semiconductors and advanced materials.

Geographic Presence

ATNL

How Tumbleweed competes

Competitive Advantages

  • Modular containers that simplify integration and certification
  • First commercial mission completed with four customers
  • Presence across Vienna and Delft

How Tumbleweed grows

Growth Strategy

Fly three missions in 2027, expand the customer base and develop Oasis Beta with sample return.

Distribution Model

Direct sales to laboratories and companies, launch-provider partnerships and shared missions.

Moat (Defensibility)

Certification know-how, payload integration, orbital hardware and mission-operating data.

Regulatory Context

Space authorisation, payload safety, export controls and launch-and-return liability.

Key Risks

  • Launch and mission risk
  • Return capability not yet demonstrated
  • Dependence on launch providers
  • Long sales cycles and space regulation

Strategic Insights

  • Standardising certification may compress time and cost more than launch-price reductions alone.
  • Return capability is important for pharma, materials and semiconductors but remains to be demonstrated.

Funding & Investors

Funding Rounds

  • 2026 - Seed: €6,9M
    Lead: PactVC

Key Investors

PactVCVanagon VenturesPrototype CapitalEWOR

Founding Team

Founders

Julian RothenbuchnerCo-founder & CEO
Leonhard GoliaschCo-founder & COO
Guillaume BraultCo-founder & CTO

Key Metrics

Clienti di Oasis Alpha4 (2026)
Prezzo di partenza per missione€15.000 (2026)
Dipendenti25 (2026)

Lessons from Tumbleweed

  • In infrastructure deeptech, a paid first mission can de-risk commercial demand before the next round.

Similar Startups

📍 Vienna

Apex.AI, Inc.

Accelerating the transition to modern software development for autonomous systems and robotics applications.

Read Analysis
📍 Vienna

Biognosys AG

Global leader in proteomics and bioanalytical solutions for life sciences and drug discovery.

Read Analysis
📍 Vienna

Cutanos GmbH

Targeted cell delivery system for dermatology and medical therapeutic applications.

Read Analysis

Sources

🎙️ Scalable Podcast — European startup stories · 🇮🇹 in Italian
Spotify 🎧 Apple